Based on 1 analysts giving stock ratings to Ensysce Biosciences Inc in the past month.
In the current month, ENSC has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ENSC average Analyst price target in the last month is 5.125.
Based on analysts' estimates, ENSC EPS is projected to reach -0.075 in FY2026Q4, following reported EPS of -4.513 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -4.51, while Ensysce Biosciences IncENSC's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.07.